Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment

Standard

Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment. / Du, Yanqin; Khera, Tanvi; Strunz, Benedikt; Deterding, Katja; Todt, Daniel; Woller, Norman; Engelskircher, Sophie Anna; Hardtke, Svenja; Port, Kerstin; Ponzetta, Andrea; Steinmann, Eike; Cornberg, Markus; Hengst, Julia; Björkström, Niklas K; Wedemeyer, Heiner; HepNet Acute HCV IV Study Group.

In: EUR J IMMUNOL, Vol. 52, No. 3, 03.2022, p. 472-483.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Du, Y, Khera, T, Strunz, B, Deterding, K, Todt, D, Woller, N, Engelskircher, SA, Hardtke, S, Port, K, Ponzetta, A, Steinmann, E, Cornberg, M, Hengst, J, Björkström, NK, Wedemeyer, H & HepNet Acute HCV IV Study Group 2022, 'Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment', EUR J IMMUNOL, vol. 52, no. 3, pp. 472-483. https://doi.org/10.1002/eji.202149457

APA

Du, Y., Khera, T., Strunz, B., Deterding, K., Todt, D., Woller, N., Engelskircher, S. A., Hardtke, S., Port, K., Ponzetta, A., Steinmann, E., Cornberg, M., Hengst, J., Björkström, N. K., Wedemeyer, H., & HepNet Acute HCV IV Study Group (2022). Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment. EUR J IMMUNOL, 52(3), 472-483. https://doi.org/10.1002/eji.202149457

Vancouver

Bibtex

@article{9512e4271c6944d58de1696fc4b543d5,
title = "Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment",
abstract = "Unconventional T cells (UTCs) are a heterogeneous group of T cells that typically exhibit rapid responses toward specific antigens from pathogens. Chronic hepatitis C virus (HCV) infection causes dysfunction of several subsets of UTCs. This altered phenotype and function of UTCs can persist over time even after direct-acting antiviral (DAA)-mediated clearance of chronic HCV. However, it is less clear if and how UTCs respond in acute, symptomatic HCV infection, a rare clinical condition, and if rapid DAA treatment of such patients reverses the caused perturbations within UTCs. Here, we comprehensively analyzed the phenotype and reinvigoration capacity of three major UTC populations, mucosal-associated invariant T (MAIT) cells, γδ T cells, and CD4 and CD8 double-negative αβ T cells (DNT cells) before, during, and after DAA-mediated clearance of acute symptomatic HCV infection. Furthermore, MAIT cell functionality was systematically studied. We observed a reduced frequency of MAIT cells. However, remaining cells presented with a near-to-normal phenotype in acute infection, which contrasted with a significant dysfunction upon stimulation that was not restored after viral clearance. Notably, DNT and γδ T cells displayed a strong activation ex-vivo in acute HCV infection, which subsequently normalized during the treatment. In addition, DNT cell activation was specifically associated with liver inflammation and inflammatory cytokines. Altogether, these data provide evidence that UTCs respond in a cell type-specific manner during symptomatic HCV infection. However, even if early treatment is initiated, long-lasting imprints within UTCs remain over time.",
author = "Yanqin Du and Tanvi Khera and Benedikt Strunz and Katja Deterding and Daniel Todt and Norman Woller and Engelskircher, {Sophie Anna} and Svenja Hardtke and Kerstin Port and Andrea Ponzetta and Eike Steinmann and Markus Cornberg and Julia Hengst and Bj{\"o}rkstr{\"o}m, {Niklas K} and Heiner Wedemeyer and {HepNet Acute HCV IV Study Group}",
note = "{\textcopyright} 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.",
year = "2022",
month = mar,
doi = "10.1002/eji.202149457",
language = "English",
volume = "52",
pages = "472--483",
journal = "EUR J IMMUNOL",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag GmbH",
number = "3",

}

RIS

TY - JOUR

T1 - Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment

AU - Du, Yanqin

AU - Khera, Tanvi

AU - Strunz, Benedikt

AU - Deterding, Katja

AU - Todt, Daniel

AU - Woller, Norman

AU - Engelskircher, Sophie Anna

AU - Hardtke, Svenja

AU - Port, Kerstin

AU - Ponzetta, Andrea

AU - Steinmann, Eike

AU - Cornberg, Markus

AU - Hengst, Julia

AU - Björkström, Niklas K

AU - Wedemeyer, Heiner

AU - HepNet Acute HCV IV Study Group

N1 - © 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

PY - 2022/3

Y1 - 2022/3

N2 - Unconventional T cells (UTCs) are a heterogeneous group of T cells that typically exhibit rapid responses toward specific antigens from pathogens. Chronic hepatitis C virus (HCV) infection causes dysfunction of several subsets of UTCs. This altered phenotype and function of UTCs can persist over time even after direct-acting antiviral (DAA)-mediated clearance of chronic HCV. However, it is less clear if and how UTCs respond in acute, symptomatic HCV infection, a rare clinical condition, and if rapid DAA treatment of such patients reverses the caused perturbations within UTCs. Here, we comprehensively analyzed the phenotype and reinvigoration capacity of three major UTC populations, mucosal-associated invariant T (MAIT) cells, γδ T cells, and CD4 and CD8 double-negative αβ T cells (DNT cells) before, during, and after DAA-mediated clearance of acute symptomatic HCV infection. Furthermore, MAIT cell functionality was systematically studied. We observed a reduced frequency of MAIT cells. However, remaining cells presented with a near-to-normal phenotype in acute infection, which contrasted with a significant dysfunction upon stimulation that was not restored after viral clearance. Notably, DNT and γδ T cells displayed a strong activation ex-vivo in acute HCV infection, which subsequently normalized during the treatment. In addition, DNT cell activation was specifically associated with liver inflammation and inflammatory cytokines. Altogether, these data provide evidence that UTCs respond in a cell type-specific manner during symptomatic HCV infection. However, even if early treatment is initiated, long-lasting imprints within UTCs remain over time.

AB - Unconventional T cells (UTCs) are a heterogeneous group of T cells that typically exhibit rapid responses toward specific antigens from pathogens. Chronic hepatitis C virus (HCV) infection causes dysfunction of several subsets of UTCs. This altered phenotype and function of UTCs can persist over time even after direct-acting antiviral (DAA)-mediated clearance of chronic HCV. However, it is less clear if and how UTCs respond in acute, symptomatic HCV infection, a rare clinical condition, and if rapid DAA treatment of such patients reverses the caused perturbations within UTCs. Here, we comprehensively analyzed the phenotype and reinvigoration capacity of three major UTC populations, mucosal-associated invariant T (MAIT) cells, γδ T cells, and CD4 and CD8 double-negative αβ T cells (DNT cells) before, during, and after DAA-mediated clearance of acute symptomatic HCV infection. Furthermore, MAIT cell functionality was systematically studied. We observed a reduced frequency of MAIT cells. However, remaining cells presented with a near-to-normal phenotype in acute infection, which contrasted with a significant dysfunction upon stimulation that was not restored after viral clearance. Notably, DNT and γδ T cells displayed a strong activation ex-vivo in acute HCV infection, which subsequently normalized during the treatment. In addition, DNT cell activation was specifically associated with liver inflammation and inflammatory cytokines. Altogether, these data provide evidence that UTCs respond in a cell type-specific manner during symptomatic HCV infection. However, even if early treatment is initiated, long-lasting imprints within UTCs remain over time.

U2 - 10.1002/eji.202149457

DO - 10.1002/eji.202149457

M3 - SCORING: Journal article

C2 - 34843107

VL - 52

SP - 472

EP - 483

JO - EUR J IMMUNOL

JF - EUR J IMMUNOL

SN - 0014-2980

IS - 3

ER -